Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Advancing LBCL Treatment Through MRD Monitoring and Allogeneic CAR T ...
Pathology Outlines - LBCL with IRF4
CAR-T Cell Therapy Package for LBCL in China | Medical Tourism China
LBCL with IRF4 H&E medium 200x
Pathology Outlines - LBCL with IRF4 rearrangement
LBCL disease monitoring by ctDNA Patients with baseline tumor sample ...
Distribution pattern of IMP3 staining intensity among NLPHL and LBCL ...
Glofitamab Phase III in 1L LBCL (SKYGLO) | Genentech
New provisional B-cell lymphoma entities. (A-D) LBCL with IRF4 ...
Clinical response in patients with LBCL treated with axi-cel is not ...
2L LBCL | YESCARTA® (axicabtagene ciloleucel)
Peter Riedell, MD, Discusses Liso-cel Research for LBCL at ASH 2023 ...
Clinical features and survival of patients with aggressive LBCL ...
ALK+ LBCL morphology. (a) The tumor grows diffusely with a sheet-like ...
FDA Approved Brentuximab Vedotin Combo for Relapsed/Refractory LBCL ...
Summary of the immunohistochemical findings in cases of LBCL (n = 42 ...
Survival curves comparing overall survival in LBCL patients with (A ...
BREYANZI® LBCL Patient Identification | For HCPs
CAR22 Shows Lasting Response in LBCL Subgroup | Blood Cancers Today
Liso-Cel Shows Clinical Benefit in Relapsed/Refractory LBCL | Targeted ...
Salvage RT Shows Local Control in LBCL After CAR T-Cell Therapy Failure
Epcoritamab Delivers 3-Year Remission in Tough LBCL Cases | Blood ...
Lyell: 'Hold' Rating Based On Phase 3 LYL314 LBCL Treatment Program ...
Glofitamab combo shows first-line potential in LBCL
Tisa-Cel Maintains Efficacy at 5-Year Analysis in R/R LBCL | CancerNetwork
LBCL CAR T治疗后复发：谁是后续治疗最优解？ - 知乎
New LBCL CNS prophylaxis guidelines by Matt Wilson et al. - OncoDaily
LBCL-292-2023-24.pdf - LIBERAL ARTS COLLEGE 2023-2024 LBCL 292: Modes ...
ctDNA Effectively Predicts LBCL Relapse | www.PhysiciansWeekly.com
Axi-cel as an effective second-line treatment for R/R LBCL patients ...
LBCL with IRF4 H&E Low 100x
Clinical Trial and Real-World Evidence Around CAR T-cell Therapy in LBCL
Outcomes following CD19-CAR-T in LBCL A A study flow diagram describing ...
Pathologic Features of Large B-cell Lymphoma (LBCL) with IRF4 ...
Large B-cell lymphomas with a phenotype of terminal B-cell ...
Large B‐cell lymphoma (LBCL): EHA Clinical Practice Guidelines for ...
Primary large B-cell lymphomas (LBCL) of immune-privileged sites (H&E ...
The current landscape of frontline large B-cell lymphoma trials | Medfyle
Table 1 from Molecular Update and Evolving Classification of Large B ...
The Role of the Tumor Microenvironment in T-Cell Redirecting Therapies ...
Diffuse large B-cell lymphoma and Burkitt lymphoma - Diagnostic ...
Morphologic, immunophenotypic, and genetic features of the localized ...
Histologically, large B‐cell lymphoma (LBCL), IRF4+ cases are often ...
Current Frontline Treatment of Diffuse Large B-Cell Lymphoma
Breyanzi for the Treatment of Large B-cell Lymphoma, US
| Flow cytometric picture of a large B-cell lymphoma (LBCL) and a ...
(Patient 1 A‐E). A, Diffuse large B‐cell lymphoma (LBCL) at relapse ...
Figure1: Patients with large B cell lymphoma (LBCL) who underwent stem ...
Alison Sehgal, MD, Describes the Phase II PILOT Study of Patients with ...
A single-cell atlas of diffuse large B cell lymphoma: Cell Reports
Redefining Precision Management of r/r Large B-Cell Lymphoma: Novel ...
Lymphoma Subtypes
血液月报 | （0元领脊柱杯）Liso-cel二线治疗R/R LBCL疗效显著（Phase 3） - 知乎
Immunohistochemically, large B‐cell lymphoma (LBCL), IRF4+ cases ...
Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients ...
What Is Breyanzi® (lisocabtagene maraleucel) for LBCL?
Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma ...
TIME and space predict response to CAR T-cell therapy in lymphoma ...
Constitutive BLyS expression contributes to NHL-B cell survival in ...
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes ...
Biologic interfaces or gray zones classical Hodgkin lymphoma and other ...
Axicabtagene Ciloleucel vs 标准二线方案对大B细胞淋巴瘤(LBCL)患者生存影响的比较研究_治疗_axi-cel_结果
Understanding LBCL: Presentation, Diagnosis, and Prognostic Indicators ...
Overview of 30 cases of LBCL-IRF4 clustered in groups according to the ...
Haematologica：早期PET在CAR T治疗LBCL中的预后价值-MedSci.cn
b:B细胞淋巴瘤(LBCL)中CAR-T细胞疗法过程中的患者流失：关注ATC - 2025年11月 - 行业研究数据 - 小牛行研
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ...
Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA ...
Relevant laboratory results of the patient. | Download Scientific Diagram
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for ...
CAR T Cell Therapy for Large B-Cell Lymphoma | Breyanzi® (lisocabtagene ...
Photomicrograph of the histopathology of ALK+LBCL displaying ...
Treatment Sequencing in LBCL: Clinical Trial and Real-World Data
Fixed-Duration Epcoritamab Is Active, Safe in Older Patients With Newly ...
Understanding LBCL: Presentation, Diagnosis, and Prognostic Indicators
Full article: Budget impact of introducing glofitamab for treatment of ...
(PDF) IRF4-rearranged Large B-cell lymphoma (LBCL) has a genomic ...
CAR-T治疗Richter综合征的疗效劣于初治LBCL和低级别B细胞淋巴瘤转化-MedSci.cn
Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non ...
CAR T治疗LBCL和MM的耐药机制和复发后治疗策略-MedSci.cn
Evolution in the Definition of Follicular Lymphoma and Diffuse Large B ...
Comprehensive Insight into Large B Cell Non-Hodgkin Lymphoma
Full article: Molecular characterization of adult IRF4 large B-cell ...
Morphological, immunohistochemical, and genetic features of LBCL-IRF4 ...
EBV-negative GZLs with LBCL-like features (cases 332 and 774). Case 332 ...
B Cell Lymphoma Uncovering The Molecular Drivers Of B Cell Lymphoma
Large B-cell lymphoma-IRF4+ in children and young people: time to ...
(PDF) P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED ...
Diffuse Large B-cell Lymphoma Stages | RITUXAN HYCELA
Outcomes of Large B-Cell Lymphoma (LBCL) Patients with Secondary ...
Diffuse Large B-Cell Lymphoma Overview - Rare Disease Advisor
Fluid Overload-Associated Large B-Cell Lymphoma: A Case Report and ...
CAR T-Cell Persistence in LBCL: Flow Cytometry Tracking – Archyde
#lbcl #lymsm #lymphoma | Lymphoma Hub
LBCL: FDA aprobó axicabtagene ciloleucel | ScienceLink • Oncología y ...
ROC curve for IMP3 expression in differentiating LBCL( including THRLBC ...
Comparison of CN profile and genetic features of adult and pediatric ...
Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present ...
Long Beach Cancer League Home Page
Large B-cell Lymphoma | Diagnose This! | Arkana Laboratories
蔡清清教授点评TRANSFORM研究，CAR-T有望跻身R/R LBCL二线治疗_患者_标准_化疗
What are the Signs and Symptoms of LBCL? - HealthTree for Large B Cell ...
Cytologic and histologic features of ALK + LBCL. A, The touch imprint ...
Primary Large B-Cell Lymphoma of Immune-Privileged Sites of the ...
Large B-Cell Lymphoma Results (LBCL) | Breyanzi® (lisocabtagene maraleucel)
